Voting Results from BioNTech's Annual General Meeting 2022 30, 2021, 06:20 AM. BioNTech Completes Acquisition of Kite's Neoantigen TCR Cell Therapy R ... After such a roaring success, BioNTech is planning to repurchase all its shares and introduce a special cash dividend of €2 a . BioNTech to Acquire Kite's Neoantigen TCR Cell Therapy R&D Platform and ... BioNTech's largest shareholders are biotech investors Thomas and Andreas Struengmann, who hold about half of the company's shares between them. MotleyFool. 7.55%. Image . That's especially true when it comes to investing. The brothers are still the largest shareholders in the Mainz-based . Their latest funding was raised on Apr 14, 2022 from a Post-IPO Equity round. Meta Materials shareholders are still a long way from a dividend. This is in line with BioNTech's capital allocation strategy and the company's commitment to delivering shareholder value," said Helmut Jeggle, Chairman of the Supervisory Board of BioNTech . . Also on the agenda is a share buyback program with a volume of up to USD 1.5 billion. BNTX - BioNTech SE Shareholders - CNNMoney.com Voting Results from BioNTech's Annual General Meeting 2022 BioNTech plans to return nearly €2 billion to shareholders through share buybacks and a special dividend following the commercial success of its Covid-19 vaccine, the company said on Wednesday. Trusted News Discovery Since 2008. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. 3 Reasons Shareholders of Moderna and BioNTech May Be In for a Shock
Omas Tomatensoße Mit Fleischwurst,
Immergrüne Sträucher Für Trockene Sonnige Standorte,
Articles B